Key result
18F-FDG PET/CT plays a crucial role in ruling out distant metastases in rare cases of alveolar rhabdomyosarcoma of the prostate, as demonstrated in a 17-year-old boy.
18F-FDG PET/CT plays a crucial role in ruling out distant metastases in pediatric and adolescent patients with rare prostate rhabdomyosarcoma.
May support 18F-FDG PET/CT for metastasis staging in rare adolescent prostatic rhabdomyosarcoma; leaves open prospective protocols.
Rhabdomyosarcoma of the prostate is a rare malignancy that usually presents in childhood and adolescence with symptoms of bladder outlet obstruction. Serum prostate-specific antigen is usually normal, and 18 F-FDG PET/CT has a crucial role to rule out distant metastases. We present a case of alveolar rhabdomyosarcoma of the prostate in a 17-year-old boy.
No takes yet. Share an insight, caveat, or question.
Datta et al. (2023) studied this question. 18F-FDG PET/CT plays a crucial role in ruling out distant metastases in rare cases of alveolar rhabdomyosarcoma of the prostate, as demonstrated in a 17-year-old boy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: